Portola Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.11.15	ALXA Gets It Back, REGN's Eylea Keeps Adding New Indications, Smooth Flows PTLA (RTTNews)
14.10.15	ENZ Settles Suit With AFFX, PTLA On Fast Track, XTLB Given Enough Time (RTTNews)
22.06.15	Portola, Bristol-Myers Report Results Of 2-nd Part Of Phase 3 ANNEXA-A Study (RTTNews)
08.04.15	Portola Reports Topline Results From Second Part Of Phase 3 ANNEXA-A Study (RTTNews)
11.03.15	PTLA Prices Offering At $40/Share (RTTNews)
03.03.15	BMY To Face FDA, XON Springs A Surprise, AERI Awaits Rocket To Deliver (RTTNews)
27.02.15	STAR Lights Up CYTX, NVAX Awaits Catalysts, VTAE Thrashed, CMRX On Watch (RTTNews)
16.02.15	Did You Make The Most Of These Secondary Offerings? (RTTNews)
06.02.15	ACT Does A Balancing Act, HSP Snapped Up, PTLA, RXDX Up After-Hours (RTTNews)
12.01.15	SCYX Rises, ARGS Crashes, AMRI Opens Wallet, NPSP Snapped Up, TNXP On Watch (RTTNews)
17.11.14	Portola,Bristol-Myers, Pfizer Announce Results From First Part Of Phase 3 ANNEXA (RTTNews)
10.11.14	Portola Pharma Loss Narrower Than Estimate (RTTNews)
02.10.14	ARDX Surges On Study Data, HBIO Opens Wallet, ZGNX On Watch, PTLA Creates Buzz (RTTNews)
01.10.14	Portola Pharma Announces Public Offering - Quick Facts (RTTNews)
01.10.14	Portola Pharma: Phase 3 ANNEXA-A Study Of Andexanet Alfa, Eliquis Met Endpoints (RTTNews)
11.06.14	Portola Pharma Announces Positive Phase 2 Data With Andexanet Alfa (RTTNews)
12.05.14	Portola Pharmaceuticals Begins Enrollment In Phase 3 Trial For Andexanet Alfa (RTTNews)
14.04.14	Portola Pharma Announces Publication Of Phase 3 APEX Study Design - Quick Facts (RTTNews)
28.03.14	EXAS Gets FDA Panel's Thumbs Up, NRX Ropes In Partners, PRPH Breathes Easy (RTTNews)
27.03.14	Portola Initiates Phase 2 Study To Evaluate Andexanet Alfa - Quick Facts (RTTNews)
20.03.14	CRME Does It Again, HRTX Extends Rally, IsoRay Sparkles, HTBX Warming Up (RTTNews)
19.03.14	Portola Initiates Phase 3 Study Of Anticoagulation Antidote Andexanet Alfa (RTTNews)
28.02.14	Portola Pharma Q4 Loss Widens - Quick Facts (RTTNews)
04.02.14	DXCM Gets FDA Nod, MRK Breathes Easy, Neovasc Takes Heart, VRX Opens Wallet (RTTNews)
13.01.14	Portola Enters Second Clinical Collaboration Deal With Bristol-Myers And Pfizer (RTTNews)
11.11.13	Portola:Andexanet Alfa Dose-dependently Reversed Xarelto's Anticoagulant Effects (RTTNews)
25.10.13	BABY Makes Big Leap, RIGL's Trial Flops, CLSN Warming Up To HEAT, NPSP On Watch (RTTNews)
21.10.13	Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences (PR Newswire)
17.10.13	Portola Pharma Prices Public Offering Of 6.37 Mln Shares At $23.75/shr (RTTNews)
15.10.13	ATRS Hits A High, CNDO's TRUST Fails, KOOL Has Some Hot News, MNKD, PLX On Watch (RTTNews)
14.10.13	Portola Pharma Announces First Phase 2 Results Of Andexanet Alfa (RTTNews)
10.10.13	ARIA Loses Pace, DVAX On The Move, BDSI, CHTP Get FDA Dates, ACUR Buys Peace (RTTNews)
09.10.13	Portola Pharma Initiates Phase 1/2 Clinical Study Of PRT2070 - Quick Facts (RTTNews)
15.08.13	Portola Pharma Posts Q2 Loss (RTTNews)
15.08.13	Portola Pharma Posts Loss - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	79.88	2.70 %	K V
Roche Hldg G	264.40	2.68 %	K V
Lonza Grp	554.20	2.29 %	K V
Swiss Re	134.85	1.70 %	K V
Novartis	90.39	1.61 %	K V
ABB	49.48	-0.26 %	K V
Geberit	513.60	-0.35 %	K V
Sika	216.90	-0.37 %	K V
Kuehne+Nagel Int	208.50	-0.43 %	K V
Holcim	88.08	-0.45 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Portola Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten